MENU

ONCT

Stock ticker: NASDAQ

PRICE

CHANGE

CAPITALIZATION

Oncternal Therapeutics (ONCT) Ownership - Who owns Oncternal Therapeutics?

Oncternal Therapeutics Inc is a clinical-stage oncology company developing first-in-class, novel therapies that target a broad spectrum of cancers with a large unmet medical need... Show more

Get AI intraday signals

#MovingAverage #Momentum #MACD #Pattern #RSI #Stochastic #Aroon #Bollinger

Profile

Industry

N/A

Address

12230 El Camino Real

Phone

+1 858 434-1113

Employees

30

Web

https://www.oncternal.com

Details

Group

Domestic Stock Funds

Category

Biotechnology

Capitalization

1.56M

P/E Ratio

N/A

Total Cash

14.58M

Projected Growth

N/A

Total Debt

191K

Revenue

N/A

Risk (Beta)

0.83

Dividend Yield

N/A

Total Cash/Share

4.93

Total Debt/Equity

N/A

Revenue/Share

null USD as % of share price

View a ticker or compare two or three

VS

VS

Interact to see
Advertisement

A.I.Advisor

published price charts

Last 5 trading days

View AI-Driven Trading for ONCT

A.I. Advisor

published General Information

General Information

a clinical-stage oncology company developing a diverse pipeline of treatments for cancers with critical unmet medical need.

Industry Biotechnology

Profile

Details

Industry

N/A

Address

12230 El Camino Real

Phone

+1 858 434-1113

Employees

30

Web

https://www.oncternal.com